A phase I study of pemetrexed in combination with docetaxel in advanced solid tumor patients

被引：0
|
作者：
Cranmer, Lee D. [1 ]
Morgan, Sherif S. [1 ]
Bauland, Amy S. [1 ]
Burruel, Yrma [1 ]
Cardenas, Jean S. [1 ]
Concannon, Terry [1 ]
Schmidt, Kathy J. [1 ]
Snyder-Walker, Robin [1 ]
Garland, Linda L. [1 ]
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.2567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2567
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I dose escalation trial of biweekly pemetrexed in combination with docetaxel in advanced solid tumors
    Garland, L. L.
    Cranmer, L., III
    Gerstner, G.
    Walker, R.
    Obregon, Y.
    Ebbinghaus, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
    Sunakawa, Yu
    Takahashi, Keishiro
    Kawaguchi, Osamu
    Yamamoto, Nobuyuki
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (05) : 1032 - 1041
  • [3] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk, LC
    Vasey, P
    Sparreboom, A
    Reigner, B
    Planting, AST
    Gordon, RJ
    Osterwalder, B
    Verweij, J
    Twelves, C
    BRITISH JOURNAL OF CANCER, 2000, 83 (01) : 22 - 29
  • [4] Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
    Yu Sunakawa
    Keishiro Takahashi
    Osamu Kawaguchi
    Nobuyuki Yamamoto
    Investigational New Drugs, 2022, 40 : 1032 - 1041
  • [5] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk L.C.
    Vasey P.
    Sparreboom A.
    Reigner B.
    Planting A.S.Th.
    Gordon R.J.
    Osterwalder B.
    Verweij J.
    Twelves C.
    British Journal of Cancer, 2000, 83 (1) : 22 - 29
  • [6] A phase I clinical and pharmacokinetic study of ipifarnib in combination with docetaxel in patients with advanced solid malignancies
    Awada, Ahmad
    Zhang, Steven
    Gil, Thierry
    de Valeriola, Dominique
    Lalami, Yassine
    De Porre, Peter
    Piccart-Gebhart, Martine J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 991 - 1003
  • [7] Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors
    Misset, JL
    Gamelin, E
    Campone, M
    Delaloge, S
    Latz, JE
    Bozec, L
    Fumoleau, P
    ANNALS OF ONCOLOGY, 2004, 15 (07) : 1123 - 1129
  • [8] A Phase I Trial of Bexarotene in Combination With Docetaxel in Patients With Advanced Solid Tumors
    Malik, Shakun M.
    Collins, Brian
    Pishvaian, Michael
    Ramzi, Pari
    Marshall, John
    Hwang, Jimmy
    CLINICAL LUNG CANCER, 2011, 12 (04) : 231 - 236
  • [9] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Syma Iqbal
    Heinz-Josef Lenz
    David R. Gandara
    Stephen I. Shibata
    Susan Groshen
    Timothy W. Synold
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 85 - 91
  • [10] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Iqbal, Syma
    Lenz, Heinz-Josef
    Gandara, David R.
    Shibata, Stephen I.
    Groshen, Susan
    Synold, Timothy W.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 85 - 91
12345